📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
279 analysed today
FollowTelegram
279
Today
150,230
All-time analysed
43,037
Positive
6,681
Negative
91,781
Neutral
8,663
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
21 announcements match the current filters (relevance ≥ 5).
Vineet Laboratories Rights Issue Committee Meeting Adjourned to Dec 6
Vineet Laboratories has adjourned its Rights Issue Committee meeting, which commenced on December 3, 2025, at 3:00 P.M., to December 6, 2025. The adjournment is to allow the committee to further consider the Issue Price, Entitlement Ratio, Record date, Issue opening and closing dates, and other modalities of the proposed Rights Issue. This is pending receipt of in-principle approval from BSE Ltd. The initial meeting on December 3rd lasted from 3:00 P.M. to 4:00 P.M.
Key Highlights
Rights Issue Committee meeting adjourned to December 6, 2025
Initial meeting commenced on December 3, 2025, at 3.00 P.M.
Initial meeting adjourned at 4.00 P.M.
Considering Issue Price, Entitlement Ratio, Record date, Issue opening and closing dates
👀 What to Watch
Investors should monitor for the announcement of the Issue Price, Entitlement Ratio, Record date, and Issue dates on December 6, 2025. Evaluate the terms of the rights issue to determine whether to participate.
